-
1
-
-
33646354927
-
Exenatide (exendin-4)-induced pancreatitis: A case report
-
10.2337/diacare.29.02.06.dc05-2043 16443920
-
PS Denker PE Dimarco 2006 Exenatide (exendin-4)-induced pancreatitis: a case report Diabetes Care 29 471 10.2337/diacare.29.02.06.dc05-2043 16443920
-
(2006)
Diabetes Care
, vol.29
, pp. 471
-
-
Denker, P.S.1
Dimarco, P.E.2
-
2
-
-
0036965113
-
The insulinotropic effect of acute exendin-4 administered to humans: Comparison of nondiabetic state to type 2 diabetes
-
DOI 10.1210/jc.87.3.1282
-
JM Egan AR Clocquet D Elahi 2002 The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes J Clin Endocrinol Metab 87 1282 1290 10.1210/jc.87.3.1282 1:CAS:528:DC%2BD38XitlWns7k%3D 11889200 (Pubitemid 36121100)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.3
, pp. 1282-1290
-
-
Egan, J.M.1
Clocquet, A.R.2
Elahi, D.3
-
3
-
-
33644840976
-
Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus
-
DOI 10.1016/j.biocel.2005.07.011, PII S1357272505002566, Diabetes: New Research and Novel Therapies
-
DD De Leon MF Crutchlow JY Ham DA Stoffers 2006 Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus Int J Biochem Cell Biol 38 845 859 10.1016/j.biocel.2005.07.011 16202636 (Pubitemid 43363416)
-
(2006)
International Journal of Biochemistry and Cell Biology
, vol.38
, Issue.5-6
, pp. 845-859
-
-
Leon, D.D.D.1
Crutchlow, M.F.2
Ham, J.-Y.N.3
Stoffers, D.A.4
-
4
-
-
0027184119
-
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
-
1:STN:280:DyaK3sznsV2lsw%3D%3D 8396143
-
R Goke HC Fehmann T Linn, et al. 1993 Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells J Biol Chem 268 19650 19655 1:STN:280:DyaK3sznsV2lsw%3D%3D 8396143
-
(1993)
J Biol Chem
, vol.268
, pp. 19650-19655
-
-
Goke, R.1
Fehmann, H.C.2
Linn, T.3
-
5
-
-
42949089442
-
Exenatide and rare adverse events
-
1:CAS:528:DC%2BD1cXlt1KjtrY%3D 18456920 discussion 1971-1972
-
SR Ahmad J Swann 2008 Exenatide and rare adverse events N Engl J Med 358 1970 1971 1:CAS:528:DC%2BD1cXlt1KjtrY%3D 18456920 discussion 1971-1972
-
(2008)
N Engl J Med
, vol.358
, pp. 1970-1971
-
-
Ahmad, S.R.1
Swann, J.2
-
6
-
-
72449188040
-
-
FDA U.S. Food and Drug Administration (exanatide) October 2007. Available from accessed 21 November 2008
-
FDA U.S. Food and Drug Administration (2007) Byetta (exanatide) October 2007. Available from www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm150839.htm, accessed 21 November 2008
-
(2007)
Byetta
-
-
-
7
-
-
33644803761
-
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
-
DOI 10.1002/hep.21006
-
X Ding NK Saxena S Lin NA Gupta FA Anania 2006 Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice Hepatology 43 173 181 10.1002/hep.21006 1:CAS:528:DC%2BD28Xpt1Snsw%3D%3D 16374859 (Pubitemid 43733604)
-
(2006)
Hepatology
, vol.43
, Issue.1
, pp. 173-181
-
-
Ding, X.1
Saxena, N.K.2
Lin, S.3
Gupta, N.4
Anania, F.A.5
-
8
-
-
0029591623
-
Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells
-
1:CAS:528:DyaK28XivFalug%3D%3D 8539259
-
MK Reddy K Baskaran A Molteni 1995 Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells Proc Soc Exp Biol Med 210 221 226 1:CAS:528:DyaK28XivFalug%3D%3D 8539259
-
(1995)
Proc Soc Exp Biol Med
, vol.210
, pp. 221-226
-
-
Reddy, M.K.1
Baskaran, K.2
Molteni, A.3
-
9
-
-
0018747714
-
Estradiol receptor assays in normal and neoplastic tissues. A possible diagnostic acid for tumor differentiation
-
1:CAS:528:DyaE1MXhvVCms7Y%3D 453784
-
A Molteni RM Bahu HA Battifora, et al. 1979 Estradiol receptor assays in normal and neoplastic tissues. A possible diagnostic acid for tumor differentiation Ann Clin Lab Sci 9 103 108 1:CAS:528:DyaE1MXhvVCms7Y%3D 453784
-
(1979)
Ann Clin Lab Sci
, vol.9
, pp. 103-108
-
-
Molteni, A.1
Bahu, R.M.2
Battifora, H.A.3
-
10
-
-
0035758111
-
Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker
-
1:CAS:528:DC%2BD3MXptlOjs78%3D
-
A Molteni JE Moulder EP Cohen, et al. 2001 Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker Exp Biol Med (Maywood) 226 1016 1023 1:CAS:528:DC%2BD3MXptlOjs78%3D
-
(2001)
Exp Biol Med (Maywood)
, vol.226
, pp. 1016-1023
-
-
Molteni, A.1
Moulder, J.E.2
Cohen, E.P.3
-
11
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
-
DOI 10.1007/BF00280883
-
DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
-
(1985)
Diabetologia
, vol.28
, Issue.7
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
-
12
-
-
33645533439
-
Exenatide: From the Gila monster to the pharmacy
-
10.1331/154434506775268698 quiz 53-54
-
C Triplitt E Chiquette 2006 Exenatide: from the Gila monster to the pharmacy J Am Pharm Assoc (2003) 46 44 52 10.1331/154434506775268698 quiz 53-54
-
(2006)
J Am Pharm Assoc
, vol.46
, pp. 44-52
-
-
Triplitt, C.1
Chiquette, E.2
-
13
-
-
34249066125
-
Acute pancreatitis: Diagnosis, prognosis, and treatment
-
17555143
-
JK Carroll B Herrick T Gipson SP Lee 2007 Acute pancreatitis: diagnosis, prognosis, and treatment Am Fam Physician 75 1513 1520 17555143
-
(2007)
Am Fam Physician
, vol.75
, pp. 1513-1520
-
-
Carroll, J.K.1
Herrick, B.2
Gipson, T.3
Lee, S.P.4
-
14
-
-
0036022407
-
Initiator caspases in apoptosis signaling pathways
-
DOI 10.1023/A:1016167228059
-
M Chen J Wang 2002 Initiator caspases in apoptosis signaling pathways Apoptosis 7 313 319 10.1023/A:1016167228059 1:CAS:528:DC%2BD38XltVSgtbw%3D 12101390 (Pubitemid 34832255)
-
(2002)
Apoptosis
, vol.7
, Issue.4
, pp. 313-319
-
-
Chen, M.1
Wang, J.2
-
16
-
-
70349120958
-
GLP-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice
-
10.2337/db09-0626
-
JA Koehler LL Baggio BJ Lamont S Ali DJ Drucker 2009 GLP-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice Diabetes 58 1604 1615 10.2337/db09-0626
-
(2009)
Diabetes
, vol.58
, pp. 1604-1615
-
-
Koehler, J.A.1
Baggio, L.L.2
Lamont, B.J.3
Ali, S.4
Drucker, D.J.5
-
17
-
-
67650245531
-
Beneficial endocrine but adverse exocrine effects of sitagliptin in the HIP rat model of type 2 diabetes, interactions with metformin
-
10.2337/db09-0058 1:CAS:528:DC%2BD1MXos1Cqu74%3D 19403868
-
AV Matveyenko S Dry HI Cox, et al. 2009 Beneficial endocrine but adverse exocrine effects of sitagliptin in the HIP rat model of type 2 diabetes, interactions with metformin Diabetes 58 1604 1615 10.2337/db09-0058 1:CAS:528:DC%2BD1MXos1Cqu74%3D 19403868
-
(2009)
Diabetes
, vol.58
, pp. 1604-1615
-
-
Matveyenko, A.V.1
Dry, S.2
Cox, H.I.3
-
18
-
-
0034032317
-
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas
-
10.2337/diabetes.49.5.741 1:CAS:528:DC%2BD3cXjsF2msrc%3D 10905482
-
DA Stoffers TJ Kieffer MA Hussain, et al. 2000 Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas Diabetes 49 741 748 10.2337/diabetes.49.5.741 1:CAS:528:DC%2BD3cXjsF2msrc%3D 10905482
-
(2000)
Diabetes
, vol.49
, pp. 741-748
-
-
Stoffers, D.A.1
Kieffer, T.J.2
Hussain, M.A.3
-
19
-
-
0026824479
-
Exendin peptides
-
1:STN:280:DyaK383ksValug%3D%3D 1574068
-
J Eng 1992 Exendin peptides Mt Sinai J Med 59 147 149 1:STN:280:DyaK383ksValug%3D%3D 1574068
-
(1992)
Mt Sinai J Med
, vol.59
, pp. 147-149
-
-
Eng, J.1
-
20
-
-
0026666235
-
Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini
-
10.1016/0167-0115(92)90044-U 1:CAS:528:DyaK38Xmt1yisLo%3D 1279756
-
R Malhotra L Singh J Eng JP Raufman 1992 Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini Regul Pept 41 149 156 10.1016/0167-0115(92)90044-U 1:CAS:528:DyaK38Xmt1yisLo%3D 1279756
-
(1992)
Regul Pept
, vol.41
, pp. 149-156
-
-
Malhotra, R.1
Singh, L.2
Eng, J.3
Raufman, J.P.4
-
21
-
-
52649162401
-
Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet
-
10.1136/gut.2007.135665 1:CAS:528:DC%2BD1cXht1KksLjJ 18579666
-
H Araki T Nishihara M Matsuda, et al. 2008 Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet Gut 57 1431 1440 10.1136/gut.2007.135665 1:CAS:528:DC%2BD1cXht1KksLjJ 18579666
-
(2008)
Gut
, vol.57
, pp. 1431-1440
-
-
Araki, H.1
Nishihara, T.2
Matsuda, M.3
-
22
-
-
57049106441
-
Exenatide and pancreatitis: An update
-
10.1517/14740330802432003 18983211
-
SC Bain JW Stephens 2008 Exenatide and pancreatitis: an update Expert Opin Drug Saf 7 643 644 10.1517/14740330802432003 18983211
-
(2008)
Expert Opin Drug Saf
, vol.7
, pp. 643-644
-
-
Bain, S.C.1
Stephens, J.W.2
|